BUZZ-Tekmira Pharmaceuticals Corp: Developing Ebola drug
** Canadian drugmaker's U.S.-listed shares up 7.6 pct at $15.36 premarket
** Tekmira hopes to produce first treatment for Ebola virus
** U.S. FDA says willing to work with companies testing Ebola drug; would consider special emergency new drug applications
** Earlier this month, FDA put clinical trial of Tekmira's TKM-Ebola on hold
** Tekmira's shares rose sharply on Friday on news Ebola outbreak in West Africa has intensified
© Thomson Reuters 2017 All rights reserved.